Edition:
United Kingdom

Athenex Inc (ATNX.OQ)

ATNX.OQ on NASDAQ Stock Exchange Global Select Market

10.76USD
24 Apr 2019
Change (% chg)

$-0.58 (-5.11%)
Prev Close
$11.34
Open
$11.37
Day's High
$11.45
Day's Low
$10.75
Volume
68,033
Avg. Vol
117,522
52-wk High
$20.90
52-wk Low
$9.87

About

Athenex, Inc. is an oncology pharmaceutical company focused on the development and commercialization of therapies for cancer diseases and supportive therapies. The Company's technology platform is organized into three categories, including Oral Absorption Platform, Src Kinase Inhibitors and Symptom Therapeutics. The Company... (more)

Overall

Beta: --
Market Cap(Mil.): $760.05
Shares Outstanding(Mil.): 67.02
Dividend: --
Yield (%): --

Financials

  ATNX.OQ Industry Sector
P/E (TTM): -- 110.36 63.23
EPS (TTM): -1.80 -- --
ROI: -90.46 7.96 11.76
ROE: -102.39 8.13 12.60

Earnings vs. Estimates